AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adkins, Y.
Right arrow Articles by Lönnerdal, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adkins, Y.
Right arrow Articles by Lönnerdal, B.
Agricola
Right arrow Articles by Adkins, Y.
Right arrow Articles by Lönnerdal, B.
American Journal of Clinical Nutrition, Vol. 77, No. 5, 1234-1240, May 2003
© 2003 American Society for Clinical Nutrition


Original Research Communication

Potential host-defense role of a human milk vitamin B-12–binding protein, haptocorrin, in the gastrointestinal tract of breastfed infants, as assessed with porcine haptocorrin in vitro1,2,3

Yuriko Adkins and Bo Lönnerdal

1 From the Department of Nutrition, the University of California, Davis.

Background: Limited information exists on the biological role of a vitamin B-12–binding protein, haptocorrin, in human milk. The expression of haptocorrin by human mammary epithelial cells and its presence in human milk suggest a potential physiologic function in breastfed infants.

Objective: We investigated the extent to which haptocorrin could withstand proteolytic degradation and exert antimicrobial activity under in vitro conditions designed to simulate the gastrointestinal tract of breastfed infants.

Design: An in vitro model that simulates infant gastric and intestinal digestion was developed. The structural stability of porcine haptocorrin after exposure to digestive enzymes (pepsin and pancreatin) was determined by sodium dodecyl sulfate–polyacrylamide gel electrophoresis, Western blot analysis, column chromatography, and matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). The antimicrobial activity of haptocorrin was determined by incubating haptocorrin with enteropathogenic Escherichia coli O127 strain 2348/69 and monitoring bacterial growth.

Results: The structural analysis of haptocorrin exposed to enzymes did not show a decrease in molecular weight, which indicated that haptocorrin can survive proteolytic degradation. Both haptocorrin exposed to digestive enzymes and undigested haptocorrin inhibited the growth of enteropathogenic E. coli and did so to a similar extent. Thus, haptocorrin in vitro not only retains its structure after exposure to proteases but also exhibits antimicrobial activity.

Conclusion: These results suggest that haptocorrin may exert a host-defense function against pathogens in the gastrointestinal tracts of breastfed infants.

Key Words: Vitamin B-12 • cobalamin • enteropathogenic E. coli • haptocorrin • human milk proteins • human milk host-defense factors • breast milk • breastfed infants • breastfeeding




This article has been cited by other articles:


Home page
J. Nutr.Home page
L. M'Rabet, A. P. Vos, G. Boehm, and J. Garssen
Breast-Feeding and Its Role in Early Development of the Immune System in Infants: Consequences for Health Later in Life
J. Nutr., September 1, 2008; 138(9): 1782S - 1790S.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. Lonnerdal
Nutritional and physiologic significance of human milk proteins
Am. J. Clinical Nutrition, June 1, 2003; 77 (6): 1537S - 1543S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The American Society for Nutrition